Global /India /Healthcare /Drug Manufacturers - General /524663

Bharat Immunologicals & Biologicals Corporation Ltd.

524663 (BIBCL)

• BSE: 524663 • Delayed

17.70INR 0.3%

0.1875 USD

As of 23 June 2026, Bharat Immunologicals & Biologicals Corporation Ltd. has a market cap of $8.08M USD, ranking #42389 globally and #3469 in India. It ranks #3749 in the Healthcare sector, and #1218 in the Drug Manufacturers - General industry.

Global Rank

42389

Country Rank

3469

Sector Rank

3749

Industry Rank

1218

Key Stats

Market Cap

$8.08MUSD

764.29M INR

Revenue (TTM)

$808.94KUSD

76.5M INR

EBITDA (TTM)

-$2.1MUSD

-198.68M INR

Net Income (TTM)

-$1.95MUSD

-184.83M INR

EBITDA Margin

-260%

Profit Margin

-242%

PS Ratio

10.0

PB Ratio

1.0

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Dhananjay Tiwary open_in_new

Founded

1989

Website

bibcol.sciencecentral.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.3%	0.2%	13%	2.6%	-15%	-12%	-25%	-26%	-60%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	524663 (BIBCL) Bharat Immunologicals & Biologicals Corp Ltd ISIN: INE994B01014 Shares Out.: Shares Outstanding: 43.18M¹ TV: TradingView: BSE: BIBCL SA: Stock Analysis: BOM: 524663 YF: Yahoo Finance: 524663.BO GF: Google Finance: BOM: 524663 BA: Barron's: 524663 MS: Morningstar: XBOM: 524663	17.70 INR	TV: TradingView: BSE: BIBCL SA: Stock Analysis: BOM: 524663 YF: Yahoo Finance: 524663.BO GF: Google Finance: BOM: 524663 BA: Barron's: 524663 MS: Morningstar: XBOM: 524663

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Bharat Immunologicals & Biologicals Corporation Ltd.

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.13B 4.27T INR 558K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.34B 1.73T INR 227K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.14B 1.43T INR 187K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.71B 1.11T INR 145K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.85B 931.67B INR 122K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.69B 916.53B INR 120K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 9M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 7M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 4M%	97.4	United States
Roche Holding AG SIX: RO	$316.71B 256.25B CHF 4M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$285.49B 215.59B GBP 4M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 3M%	15.1	United States

chevron_leftBack